Weston Brain Institute - Early Phase Clinical Trials: Canada

Early Phase Clinical Trials: Canada
(Rolling applications)

Funding for clinical trials and clinical trial sub-studies that accelerate the development of therapeutics for neurodegenerative diseases of aging
Maximum $1,500,000 over up to 4 years

NEW for 2018
  • The Institute has updated which tools are in scope. Please read What We Fund before applying to ensure your project is in scope
  • The Early Phase Clinical Trials: Canada program will be run on a rolling basis

Institute definition of neurodegenerative diseases of aging: 

  • Alzheimer’s disease
  • Dementia with Lewy bodies
  • Frontotemporal dementia
  • Multiple system atrophy
  • Parkinson’s disease
  • Progressive supranuclear palsy
  • Vascular contributions to the above diseases
  • Prodromes to the above diseases
FOR MORE INFORMATION     

www.westonbraininstitute.ca/early-phase-clinical-trials-canada

416-935-4056

neuro@weston.ca
 

 

Application Procedures

  1. Review all program information and determine whether your project is in scope
  2. Register or sign in to our online grants management system
  3. Complete and submit a Letter of Intent (LOI)
    • If selected, applicants will be invited to submit a full Proposal
    • Applicants can expect to receive the outcome of their LOI application within ~2 months of submission
  4. Complete and submit a full Proposal (by invite only)

Eligibility Summary

Principal applicant must be:

  1. At or above the level of Assistant Professor or equivalent
  2. Affiliated with a Canada Revenue Agency-qualified donee institution located in Canada

Project must be:

  1. A clinical trial(s) and/or a clinical trial sub-study(s) that accelerates the development of therapeutics for neurodegenerative diseases of aging
  2. The development of a therapeutic and/or tool

Deadline

Monday, 31 December 2018

Annual Value

$1,500,000 over 4 years